Patients in the moderate and high disease activity cohorts reported significantly reduced health state utility values and HRQoL scores compared with the reference cohort.
Face pain is an intense or dull and throbbing or stabbing pain felt in any part of the face. Face pain may occur due to infection, injury or a neurological cause.
Patients with rheumatic disease treated with biosimilar SDZ ETN reported high treatment persistence at month 12 as well as comparable safety and efficacy.